Pfizer Inc (PFE) Quote

What are the ingredients?

In the next round

Of vaccines

Vexari, any questions???

PFE on fire! Market sees right through the nonsense...  ST target: $30

keep digging mister propaganda: https://petermcculloughmd.substack.com/p/new-study-covid-19-mrna-injections?publication_id=1119676&post_id=154280211&isFreemail=true&r=x7hm&triedRedirect=true

Cleveland Clinic

Nope...

Nope....

Interesting

To say the least

Dive bomber

In and out

https://www.statista.com/statistics/1318652/covid-vaccine-lawsuits-industry/

yes, it will get better after bankruptcy. I plan on buying in at that time or instruct my grand kids to do so.

why no answer? perhaps mr. biotick works for pfizzer.

How many people get it? The spike protein stays in the body and continues to do damage as you age.
Do investors think this is going away any time soon especially now that some real honest folks are about
to run the show? Tik Tok
https://petermcculloughmd.substack.com/p/catastrophic-neurological-and-psychiatric?publication_id=1119676&post_id=154201714&isFreemail=true&r=x7hm&triedRedirect=true

Why would that be?
Complete horse hockey..

Complete horse hockey..

The bird

Is a metamorphical germ

Eating

Dead cell debris

Can not catch something that doesn't exist

Facts don't lie

Open to board discussion

Yep, otherwise they would not be cutting out even some of the most promising collaborations. They are going to have scrap others too in order to stave off bankruptcy possibility in the near future with the pending and growing lawsuits. Other surprises may be waiting too in the form of new and real scrutiny by RFKjr
and the new FDA commissioner. Things are looking ugly and Pfizer is going to pay the consequences for cheating the system, withholding data, and corrupt political collaborations. Not good Pfizer. Looking for investor lawsuits to gain strength.
https://www.businesswire.com/news/home/20241230895593/en/Sangamo-Therapeutics-to-Regain-Full-Rights-to-Hemophilia-A-Gene-Therapy-Program-Following-Pfizer%E2%80%99s-Decision-to-Cease-Development-of-Giroctocogene-Fitelparvovec

imo...

Wikipedia • Coronavirus disease 2019 is a contagious disease caused by the coronavirus SARS-CoV-2. The disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID-19 can vary but often include fever, fatigue, cough, breathing difficulties, loss of smell, and loss of taste.

Like a snake bit me...... PFE



PFE


(shivering)


IHuser

Yup, this horseshit is being pumped by Wall Street crooks, cooking the books. It's over for big pharma.

Eli Lilly and Company & Pfizer Inc. are a disaster in the making.

When financial guidance

Is based on a lie

Where does one go

From there

They knew what they were doing

Nothing can stop

What is coming

imo...you are postulating and swaying perception without addressing the science or patents for insured improved health... yea that's because.. I have the market on my side....especially the women now.....and this pos is a done issue stick a fork in it and go play in traffic.....-look at the share price now blue boy ~


PFE





IHuse4

imo...you are very provacative and could wind up bankrupting this entire scam...and should be mindful of the implications...PFE


OK~ go fuck off




PFE



IHuser

imo...Pfizer sponsoring New Years Cornhole tournament in the Hamptons..... get signed up for Viagra CORN Holing into the new year with your billionaire pals.... ...don't say we didn't tell you about a good time and bid flu shots and Polio supplements are door prizes!! , Yaaaaaaay


PFE




IHuser

Gaining strength

Against the cartels grip

Tide is turning

Retribution

Is near

It's all about right and wrong. It is coming down to that. PFE will pay the piper.

The fall of the vaccine agenda

Is the fall of big pharma

The soul of humanity

Is being fought

In health care

Expanding awareness

Is key

Yes, It's over for big Pharma!

The gloves come off with Big Pharma 2025

imo...yes I am here to pump Pfizer biofunctionality in public restrooms....when my Peter pees and the bunghole is opened we are all about Pfizer watching what's going
On what's why I'm bullish

PFE



IHuser

Genocide must be gentle

So as not to alarm

Those chosen

Pfizer has been exploring new treatments for mood disorders and has a longstanding interest in neurology. It has been over 12 years since their addition of Lyrica for GAD. Their acquisition of MindMed would complement their existing CNS pipeline, particularly for disorders such as anxiety.

Wonder if they would take on that small biotech. Anyone have thoughts?

https://m3.gab.com/media_attachments/59/1a/1f/591a1f4955dfe351d818c6853909918b.webp?width=568

The FDA is rushing to Pfizer's aid before the new administration brings out the machete. Notice this news comes out during the Christmas sell off in an effort to slow the massive selling.
So with their COVID "cure" they dumped poison into our bodies that has produced cancers at an alarming new rate for which they are granted alarming new approvals. And this is not the first time either. A little historical DD is appropriate.

I might watch ever so closely for the chance at a quick DEAD CAT BOUNCE and flip.
https://kirschsubstack.com/p/the-cfr-from-the-pfizer-trial-show?publication_id=548354&post_id=153595752&isFreemail=true&r=x7hm&triedRedirect=true

Pfizer #1 worldwide scam of all time. https://kirschsubstack.com/p/the-cfr-from-the-pfizer-trial-show?publication_id=548354&post_id=153595752&isFreemail=true&r=x7hm&triedRedirect=true

Going down, maybe for good....hopefully, and making the world a safer, healthier place.

...imo... colorectoral cancer must be stopped PFE... ...and boogie people off social PFE media... with chapstick lubricant_________






PFE



IHuser

How long were the trials

Before it was approved U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer

https://www.biospace.com/press-releases/u-s-fda-approves-pfizers-braftovi-combination-regimen-as-first-line-treatment-of-braf-v600e-mutant-metastatic-colorectal-cancer

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer

https://www.biospace.com/press-releases/u-s-fda-approves-pfizers-braftovi-combination-regimen-as-first-line-treatment-of-braf-v600e-mutant-metastatic-colorectal-cancer

Some humor

Pharmer's Market Comedy

You must have bought this in the $40-$50's due to your bottomless bitterness on this board. It will get better..

Critical thinking

Double message

While proving a point imo...a guy named TRUMP said "some" vaccines are "good" like the Polio one.... uhhhh smh....everybody had Polio in the 16th and 17th and 18th Centuries...~ what a joke. PFE

imo...sir with all due respect you have rendered yourself incompetent, abrasive , and inconsequential with respect to this highly contested issue...tyvm

PFE




IHuser

imo... elect select whoever....I will destroy anything you got...pump bs however...I already told this board...PFE

...I own this issue...PFE...this is my planet and I want it PFE off of my planet....now....thank you.




PFE



IHuser

imo... practically ZERO % of buyers driving the sp up today were taking long positions...they are merely closing out short positions..for tax considerations....nobody wants any more products from "stogy" Pfizer....believe me~



PFE



IHuser

PFE is +4.5% today, which is a big move for such a “stodgy” name. The impetus for the uptick, IMO, is not PFE’s 2025 guidance per se, which was consistent with Street expectations, but rather the comment that the guidance assumes a phase-3 trial for Danuglipron starts during 2025.

PFE issues 2025 financial guidance…

https://s28.q4cdn.com/781576035/files/doc_events/2024/Dec/17/FINAL-PFE-2025-Financial-Guidance-Press-Release.pdf
• Guidance for 2025 sales is $61-64B, up $1.2B from the range of $59.8-62.8B in 2024 guidance after excluding $1.2B of 2024 non-recurring Paxlovid sales to the US federal government stockpile. Thus, on an apples-to-apples basis, 2025 sales growth is expected to be flat to +5%.

• The 2025 sales guidance includes a $1B hit from the Medicare Part- D changes dictated by the IRA, i.e. drugmakers’ mandatory contributions to cover Part-D patients’ deductibles so that each patient’s annual out-of-pocket costs do not exceed $2,000.

• The 2025 sales guidance excludes pro rate equity income from Haleon because PFE is now a <20% shareholder in Haleon.

• Guidance for 2025 non-GAAP EPS is $2.80-3.00, up 10-18% from the 2024 range of $2.45-2.65 after excluding $0.30 of non-recurring 2024 earnings attributable to the Paxlovid item described above.

• 2025 COVID-related revenue is expected to be roughly the same as in 2024, excluding the $1.2B non-recurring Paxlovid item described above.

• 3.25x end-of-2025 target for debt/EBIDTA leverage.

• $500M in efficiency cost reductions to be realized during 2025, which is in addition to the $4.0B in such reductions already achieved during 2024.

CC slides:
https://s28.q4cdn.com/781576035/files/doc_events/2024/Dec/17/FINAL-Full-Year-2025-Guidance-Charts.pdf

imo... it doesn't matter now the bulls have absolutely nothing to say with any integrity whatsoever~PFE

...i own this pos ... me and my battle wounded crew.



PFE




IHuser

imo... axe, my man seriously, brother you need to really r3lax cuz - man take a little time with the family you know 2hat I'm sayn..s9me you time baby~

PFE


IHuser

imo....Axel......the whole market knows your heart is not in pumping this nowhere swine sickness gimmick clot stroke scam jab bullshit.....we actually kinda like you and think you deserve a chicken dinner~ PFE

PFE



IHuser

imo... when my progression-free time runs out on my PFE script~ ...i ~ ../^\____^__/^^\_^\________________________________________________________________________________________________________________________________________________________________________________Flat line_________________




PFE




IHuser

Ibrance extended median progression-free survival (PFS) by more than 50% in patients with first-line HR+, HER2+ metastatic breast cancer when combined with anti-HER2 and endocrine therapy. The Phase III PATINA trial compared Ibrance to standard of care first-line maintenance therapy after chemotherapy. Median PFS was 44.3 months for the Ibrance group as compared to 29.1 months for those on the standard of care regimen.

https://www.biospace.com/drug-development/pfizers-ibrance-improves-survival-in-new-breast-cancer-indication